In silico identification and in vitro expression analysis of breast cancer-related m⁶A-SNPs

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
   Google Scholar
• Momenimovahed Z, Salehiniya H. Epidemiological characteristics of and risk factors for breast cancer in the world. Breast Cancer (Dove Med Press). 2019;11:151–164.
   Google Scholar
• Lilyquist J, Ruddy KJ, Vachon CM, et al. Common genetic variation and breast cancer risk - Past, present, and future. Cancer Epidemiol Biomarkers Prev. 2018;27(4):380–394.
   Google Scholar
• Bhat SA, Majid S, Wani HA, et al. Diagnostic utility of epigenetics in breast cancer – a review. Cancer Treat Res Commun. 2019;19:100125.
   Google Scholar
• Maity A, Das B. N6-methyladenosine modification in mRNA: machinery, function and implications for health and diseases. FEBS J. 2016;283(9):1607–1630.
   Google Scholar
• Wang Y, Zhao JC. Update: mechanisms underlying N6-methyladenosine modification of eukaryotic mRNA. Trends Genet. 2016;32(12):763–773.
   Google Scholar
• Linder B, Grozhik AV, Olarerin-George AO, et al. Single-nucleotide-resolution mapping of m6A and m6Am throughout the transcriptome. Nat Methods. 2015;12(8):767–772.
   Google Scholar
• Meyer KD, Jaffrey SR. The dynamic epitranscriptome: N6-methyladenosine and gene expression control. Nat Rev Mol Cell Biol. 2014;15(5):313–326.
   Google Scholar
• Cao G, Li HB, Yin Z, et al. Recent advances in dynamic m6A RNA modification. Open Biol. 2016;6(4):160003.
   Google Scholar
• Chen XY, Zhang J, Zhu JS. The role of m6A RNA methylation in human cancer. Mol Cancer. 2019;18(1):103.
   Google Scholar
• Jiang S, Xie Y, He Z, et al. m6ASNP: a tool for annotating genetic variants by m6A function. Gigascience. 2018;7(5):giy035.
   Google Scholar
• Zheng Y, Nie P, Peng D, et al. M6AVar: a database of functional variants involved in m6A modification. Nucleic Acids Res. 2018;46(D1):D139–145.
   Google Scholar
• Lin W, Xu H, Wu Y, et al. In silico genome-wide identification of m6A-associated SNPs as potential functional variants for periodontitis. J Cell Physiol. 2020;235(2):900–908.
   Google Scholar
• Sun X, Dai Y, Tan G, et al. Integration analysis of m6A-SNPs and eQTLs associated with sepsis reveals platelet degranulation and Staphylococcus aureus infection are mediated by m6A mRNA methylation. Front Genet. 2020;11:7.
   Google Scholar
• Slobodin B, Dikstein R. So close, no matter how far: multiple paths connecting transcription to mRNA translation in eukaryotes. EMBO Rep. 2020;21(9):e50799.
   Google Scholar
• Mo XB, Zhang YH, Lei SF. Genome-wide identification of N6-methyladenosine (m6A) SNPs associated with rheumatoid arthritis. Front Genet. 2018;9:299.
   Google Scholar
• Mo XB, Zhang YH, Lei SF. Genome-wide identification of m6A-associated SNPs as potential functional variants for bone mineral density. Osteoporos Int. 2018;29(9):2029–2039.
   Google Scholar
• Hu Y, Zhao X. Role of m6A in osteoporosis, arthritis and osteosarcoma (Review). Exp Ther Med. 2021;22:926.
   Google Scholar
• Mo XB, Lei SF, Zhang YH, et al. Detection of m6A-associated SNPs as potential functional variants for coronary artery disease. Epigenomics. 2018;10(10):1279–1287.
   Google Scholar
• Lin W, Xu H, Yuan Q, et al. Integrative genomic analysis predicts regulatory role of N6-methyladenosine-associated SNPs for adiposity. Front Cell Dev Biol. 2020;8:551.
   Google Scholar
• Mo X, Lei S, Zhang Y, et al. Genome-wide enrichment of m6A-associated single-nucleotide polymorphisms in the lipid loci. Pharmacogenomics J. 2019;19(4):347–357.
   Google Scholar
• Qiu X, He H, Huang Y, et al. Genome-wide identification of m6A-associated single-nucleotide polymorphisms in Parkinson’s disease. Neurosci Lett. 2020;737:135315.
   Google Scholar
• Sebastian-delaCruz M, Olazagoitia-Garmendia A, Gonzalez-Moro I, et al. Implication of m6A mRNA methylation in susceptibility to iflammatory bowel disease. Epigenomes. 2020;4(3):16.
   Google Scholar
• Zhao H, Jiang J, Wang M, et al. Genome-wide identification of m6A-associated single-nucleotide polymorphisms in colorectal cancer. Pharmgenomics Pers Med. 2021;14:887–892.
   Google Scholar
• Chen M, Lin W, Yi J, et al. Exploring the epigenetic regulatory role of m6A-associated SNPs in type 2 diabetes pathogenesis. Pharmgenomics Pers Med. 2021;14:1369–1378.
   Google Scholar
• Ruan X, Tian M, Kang N, et al. Genome-wide identification of m6A-associated functional SNPs as potential functional variants for thyroid cancer. Am J Cancer Res. 2021;11(11):5402–5414.
   Google Scholar
• Xuan Z, Zhang Y, Jiang J, et al. Integrative genomic analysis of N6-methyladenosine-single nucleotide polymorphisms (m6A-SNPs) associated with breast cancer. Bioengineered. 2021;12(1):2389–2397.
   Google Scholar
• Grossman RL, Heath AP, Ferretti V, et al. Toward a shared vision for cancer genomic data. N Engl J Med. 2016;375(12):1109–1112.
   Google Scholar
• Buniello A, Macarthur JAL, Cerezo M, et al. The NHGRI-EBI GWAS Catalog of published genome-wide association studies, targeted arrays and summary statistics 2019. Nucleic Acids Res. 2019;47(D1):D1005–D1012.
   Google Scholar
• Cariaso M, Lennon G. SNPedia: a wiki supporting personal genome annotation, interpretation and analysis. Nucleic Acids Res. 2012;40( Database issue):D1308–1312.
   Google Scholar
• Bruno AE, Li L, Kalabus JL, et al. miRdSNP: a database of disease-associated SNPs and microRNA target sites on 3′UTRs of human genes. BMC Genomics. 2012;13:44.
   Google Scholar
• Liu C-J, Fu X, Xia M, et al. Guo A-Y. miRNASNP-v3: a comprehensive database for SNPs and disease-related variations in miRNAs and miRNA targets. Nucleic Acids Res. 2021;49(D1):D1276–1281.
   Google Scholar
• Yue M, Zhou D, Zhi H, et al. MSDD: a manually curated database of experimentally supported associations among miRNAs, SNPs and human diseases. Nucleic Acids Res. 2018;46(D1):D181–D185.
   Google Scholar
• Bhattacharya A, Ziebarth JD, Cui Y. SomamiR: a database for somatic mutations impacting microRNA function in cancer. Nucleic Acids Res. 2013;41(DI):D977–982.
   Google Scholar
• Howe KL, Achuthan P, Allen J, et al. Ensembl 2021. Nucleic Acids Res. 2021;49(DI):D884–891.
   Google Scholar
• Ward LD, Kellis M. HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants. Nucleic Acids Res. 2012;40(D1):D930–934.
   Google Scholar
• Barrett T, Wilhite SE, Ledoux P, et al. NCBI GEO: archive for functional genomics data sets - Update. Nucleic Acids Res. 2013;41(D1):D991–995.
   Google Scholar
• Turashvili G, Bouchal J, Baumforth K, et al. Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis. BMC Cancer. 2007;7(1):55.
   Google Scholar
• Kretschmer C, Sterner-Kock A, Siedentopf F, et al. Identification of early molecular markers for breast cancer. Mol Cancer. 2011;10(1):15.
   Google Scholar
• Li JH, Liu S, Zhou H, et al. starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 2014;42(DI):D92–97.
   Google Scholar
• Auton A, Abecasis GR, Altshuler DM, et al. A global reference for human genetic variation. Nature. 2015;526(7571):68–74.
   Google Scholar
• Marshall OJ. PerlPrimer: cross-platform, graphical primer design for standard, bisulphite and real-time PCR. Bioinformatics. 2004;20(15):2471–2472.
   Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods. 2001;25(4):402–408.
   Google Scholar
• Tan SC. Use of arbitrary reference genes may lead to misleading conclusions. Gynecol Obstet Invest. 2019;84(5):519–520.
   Google Scholar
• Schmid H, Cohen CD, Henger A, et al. Validation of endogenous controls for gene expression analysis in microdissected human renal biopsies. Kidney Int. 2003;64(1):356–360.
   Google Scholar
• Yin WZ, Yang QW, Niu K, et al. Validation of reference genes for the normalization of RT-qPCR expression studies on human laryngeal cancer and hypopharyngeal cancer. Eur Rev Med Pharmacol Sci. 2019;23(10):4199–4209.
   Google Scholar
• Meyer KD, Patil DP, Zhou J, et al. 5′ UTR m(6)A promotes cap-independent translation. Cell. 2015;163(4):999–1010.
   Google Scholar
• Ke S, Alemu EA, Mertens C, et al. A majority of m6A residues are in the last exons, allowing the potential for 3′ UTR regulation. Genes Dev. 2015;29(19):2037–2053.
   Google Scholar
• Meyer KD, Saletore Y, Zumbo P, et al. Comprehensive analysis of mRNA methylation reveals enrichment in 3′ UTRs and near stop codons. Cell. 2012;149(7):1635–1646.
   Google Scholar
• Ardlie KG, Deluca DS, Segrè AV. Human genomics. The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans. Consortium Gte. Science. 2015;348(6235):648–660.
   Google Scholar
• Kheradpour P, Kellis M. Systematic discovery and characterization of regulatory motifs in ENCODE TF binding experiments. Nucleic Acids Res. 2014;42(5):2976–2987.
   Google Scholar
• Zuker M. Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res. 2003;31(13):3406–3415.
   Google Scholar
• Wei CY, Tan QX, Zhu X, et al. Expression of CDKN1A/p21 and TGFBR2 in breast cancer and their prognostic significance. Int J Clin Exp Pathol. 2015;8(11):14619–14629.
   Google Scholar
• Wang F, Ma YL, Zhang P, et al. A genetic variant in microRNA-196a2 is associated with increased cancer risk: a meta-analysis. Mol Biol Rep. 2012;39(1):269–275.
   Google Scholar
• Wang PY, Gao ZH, Jiang ZH, et al. The associations of single nucleotide polymorphisms in miR-146a, miR-196a and miR-499 with breast cancer susceptibility. PLoS One. 2013;8(9):e70656.
   Google Scholar
• Zhang H, Su YL, Yu H, et al. Meta-analysis of the association between miR-196a-2 polymorphism and cancer susceptibility. Cancer Biol Med. 2012;9(1):63–72.
   Google Scholar
• Hu Z, Liang J, Wang Z, et al. Common genetic variants in pre-microRNAs were associated with increased risk of breast cancer in Chinese women. Hum Mutat. 2009;30(1):79–84.
   Google Scholar
• Zhao H, Xu J, Zhao D, et al. Somatic mutation of the SNP rs11614913 and its association with increased MIR 196A2 expression in breast cancer. DNA Cell Biol. 2016;35(2):81–87.
   Google Scholar
• Deng YN, Xia Z, Zhang P, et al. Transcription factor RREB1: from target genes towards biological functions. Int J Biol Sci. 2020;16(8):1463–1473.
   Google Scholar
• Choupani J, Nariman-Saleh-Fam Z, Saadatian Z, et al. Association of mir-196a-2 rs11614913 and mir-149 rs2292832 polymorphisms with risk of cancer: an updated meta-analysis. Front Genet. 2019;10:186.
   Google Scholar
• Catucci I, Yang R, Verderio P, et al. Evaluation of SNPs in miR-146a, miR196a2 and miR-499 as low-penetrance alleles in German and Italian familial breast cancer cases. Hum Mutat. 2010;31(1):E1052–1057.
   Google Scholar
• Jedlinski DJ, Gabrovska PN, Weinstein SR, et al. Single nucleotide polymorphism in hsa-mir-196a-2 and breast cancer risk: a case control study. Twin Res Hum Genet. 2011;14(5):417–421.
   Google Scholar
• Mousses S, Özçelik H, P DL, et al. Two variants of the CIP1/WAF1 gene occur together and are associated with human cancer. Hum Mol Genet. 1995;4(6):1089–1092.
   Google Scholar
• Bae I, Fan S, Bhatia K, et al. Relationships between G1 arrest and stability of the p53 and p21CiP1/Waf1 proteins following gamma-irradiation of human lymphoma cells. Cancer Res. 1995;55(11):2387–2393.
   Google Scholar
• Zhang Y, Fujita N, Tsuruo T. Caspase-mediated cleavage of p21Waf1/Cip1 converts cancer cells from growth arrest to undergoing apoptosis. Oncogene. 1999;18(5):1131–1138.
   Google Scholar
• Abbas T, Dutta A. P21 in cancer: intricate networks and multiple activities. Nat Rev Cancer. 2010;9(6):400–414.
   Google Scholar
• Kreis -N-N, Louwen F, Yuan J. The multifaceted p21 (Cip1/Waf1/CDKN1A) in cell differentiation, migration and cancer therapy. Cancers (Basel). 2019;11(9):1220.
   Google Scholar
• Carvalho INSR, de Oliveira Reis AH, Cabello PH, et al. Polymorphisms of CDKN1A gene and risk of retinoblastoma. Carcinogenesis. 2013;34(12):2774–2777.
   Google Scholar
• Lotfi Garavand A, Mohammadi M, Mohammadzadeh S. Evaluation of TP53 codon 72, P21 codon 31, and MDM2 SNP309 polymorphisms in Iranian patients with acute lymphocytic leukemia. Reports Biochem Mol Biol. 2020;9(1):26–32.
   Google Scholar
• Lin YC, Hour TC, Tsai YC, et al. Preliminary evidence of polymorphisms of cell cycle regulatory genes and their roles in urinary tract urothelial cancer susceptibility and prognosis in a Taiwan population. Urol Oncol Semin Orig Investig. 2017;35(9):543.e7–543.e16.
   Google Scholar
• Själander A, Birgander R, Rannug A, et al. Association between the p21 codon 31 A1 (arg) allele and lung cancer. Hum Hered. 1996;46(4):221–225.
   Google Scholar
• Li G, Liu Z, Sturgis EM, et al. Genetic polymorphisms of p21 are associated with risk of squamous cell carcinoma of the head and neck. Carcinogenesis. 2005;26(9):1596–1602.
   Google Scholar
• Barbieri RB, Bufalo NE, Secolin R, et al. Polymorphisms of cell cycle control genes influence the development of sporadic medullary thyroid carcinoma. Eur J Endocrinol. 2014;171(6):761–767.
   Google Scholar
• Cox A, Dunning AM, Garcia-Closas M, et al. A common coding variant in CASP8 is associated with breast cancer risk. Nat Genet. 2007;39(3):352–358.
   Google Scholar
• Driver KE, Song H, Lesueur F, et al. Association of single-nucleotide polymorphisms in the cell cycle genes with breast cancer in the British population. Carcinogenesis. 2008;29(2):333–341.
   Google Scholar
• Mao Y, Dong L, Liu X-M, et al. m6A in mRNA coding regions promotes translation via the RNA helicase-containing YTHDC2. Nat Commun. 2019;10(1):5332.
   Google Scholar
• Machnik M, Cylwa R, Kiełczewski K, et al. The expression signature of cancer-associated KRAB-ZNF factors identified in TCGA pan-cancer transcriptomic data. Mol Oncol. 2019;13(4):701–724.
   Google Scholar
• Sobocińska J, Molenda S, Machnik M, et al. KRAB-ZFP transcriptional regulators acting as oncogenes and tumor suppressors: an overview. Int J Mol Sci. 2021;22(4):2212.
   Google Scholar
• Sun M, Ju J, Ding Y, et al. The signaling pathways regulated by KRAB zinc-finger proteins in cancer. Biochim Biophys Acta Rev Cancer. 2022;1877(3):188731.
   Google Scholar
• Wang J, Zhang X, Ling J, et al. KRAB-containing zinc finger protein ZNF496 inhibits breast cancer cell proliferation by selectively repressing ERα activity. Biochim Biophys Acta Gene Regul Mech. 2018;1861(9):841–853.
   Google Scholar